Report Library
View More
Dealmaking Quarterly Statistics, Q2...
August 4, 2026
Financing Quarterly Statistics, Q2 ...
August 4, 2026
Datamonitor Healthcare CV&Met: Isch...
August 4, 2026
Datamonitor Healthcare Infectious D...
August 4, 2026
Datamonitor Healthcare Oncology: NH...
August 4, 2026
Datamonitor Healthcare Oncology: Ga...
August 4, 2026
Datamonitor Healthcare Oncology: Me...
August 4, 2026
Gene, Cell, & RNA Therapy Landscape...
July 29, 2026
Alopecia Areata: KOL Expectations o...
July 29, 2026
Schizophrenia KOL Interview - UK
July 29, 2026
Hemophilia KOL Interview - Germany
July 27, 2026
Hemophilia KOL Interview - US, Midw...
July 27, 2026
Hemophilia KOL Interview - US, West
July 27, 2026
IgA Nephropathy: Five Trends Reshap...
July 27, 2026
Multiple Sclerosis (MS) KOL Intervi...
July 24, 2026
Multiple Sclerosis (MS) KOL Intervi...
July 23, 2026
Multiple Sclerosis (MS) KOL Intervi...
July 22, 2026
Multiple Sclerosis (MS) KOL Intervi...
July 22, 2026
Datamonitor Healthcare CV&Met: Syst...
July 22, 2026
Datamonitor Healthcare Urology: Ove...
July 22, 2026
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 8/3/26 | Omeros (OMER) | Yartemlea for Transplant-Associated Thrombotic Microangiopathy (TA-TMA) | Subscribers Only | Subscribers Only | Subscribers Only |
| 7/30/26 | CEL-SCI (CVM) | Multikine for Head and Neck Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 7/29/26 | Nippon (4516) | deramiocel for Duchenne Muscular Dystrophy (DMD) | Subscribers Only | Subscribers Only | Subscribers Only |
| 7/28/26 | Altimmune (ALT) | pemvidutide for Alcohol Use Disorder | Subscribers Only | Subscribers Only | Subscribers Only |
| 7/27/26 | AstraZeneca (AZN) | sonesitatug vedotin for Esophageal Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 06/25/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 06/25/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 06/26/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 09/08/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 09/17/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |